🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the safety and efficacy of once dai...
Status
Completed
Location
Kirk Barber Research
Start Date
2010-05
Trial ID
NCT01120223
Treatments Being Tested
A Topical Treatment Optimisation Programme (TTOP) has been developed by the...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01587755
Enstilar in combination with Taltz for plaque psoriasis....
Status
Recruiting
Location
Psoriasis Treatment Center of Central New Jersey
Start Date
2020-04-28
Trial ID
NCT04372277
Treatments Being Tested
The purpose of this study is to evaluate the anti-psoriatic effect of LP011...
Status
Completed
Location
Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD)
Start Date
2015-04
Trial ID
NCT02416258
The purpose of this study is to assess the feasibility and safety of topica...
Status
Unknown
Location
University Hospital Geneva
Start Date
2016-11
Trial ID
NCT02999776
Changes in microbiome have been reported recently in psoriasis lesions comp...
Status
Completed
Location
CHU de Nice
Start Date
2018-09-24
Trial ID
NCT03584360
The purpose of the study is to evaluate the safety and efficacy of once dai...
Status
Completed
Location
Rady Children's Hospital San Diego
Start Date
2010-04
Trial ID
NCT01083758
Treatments Being Tested
This study is an exploratory study to evaluate the effectiveness, safety an...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-09-26
Trial ID
NCT00358384
Treatments Being Tested
To demonstrate the superiority of the efficacy of the test and reference pr...
Status
Completed
Location
Catawba Research, LLC
Start Date
2018-10-22
Trial ID
NCT03880357
Treatments Being Tested
4 weeks of adjunctive therapy of Enstilar® QD followed by 12 weeks QOD to p...
Status
Recruiting
Location
Psoriasis Treatment Center of Central New Jersey
Start Date
2019-01-16
Trial ID
NCT03827876
Treatments Being Tested